We are live on
!
Find out more
PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
1-Year Est. Return
3.35%
This Fund
S&P 500
This Quarter
Est. Return
+118.15%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$109M
(+55%)
Cap. Flow
-$8.02M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
AGRX
Agile Therapeutics
AGRX
|
+$7.12M |
| 2 |
ZSAN
Zosano Pharma Corporation
ZSAN
|
+$2.46M |
| 3 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
+$2.4M |
| 4 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$1.11M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$13.8M |
| 2 |
IMDZ
Immune Design Corp.
IMDZ
|
+$7.35M |
Sector Composition
| 1 | Healthcare | 69.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $200M | 65.32% |
4,780,188
+39,001
| +0.8% | +$1.11M |
|
|
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
| $51M | 16.62% |
2,414,040
-281,717
| -10% | -$7.35M |
|
|
AGRX
3
DELISTED
Agile Therapeutics
AGRX
| $43.3M | 14.12% |
2,334
+406
| +21% | +$7.12M |
|
|
ANTH
4
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $8.49M | 2.77% |
237,500
+81,250
| +52% | +$2.4M |
|
|
ZSAN
5
DELISTED
Zosano Pharma Corporation
ZSAN
| $2.32M | 0.76% |
+328
| New | +$2.46M |
|
6
Savara
SVRA
$1.17B
| $1.24M | 0.4% |
36,455
| – | – |
|
|
ACHN
7
DELISTED
Achillion Pharmaceuticals
ACHN
| – | – |
-1,122,957
| Closed | -$13.8M |
|
Similar funds
CLA
HC
SF
SCM
DIV
MGPI
MCAI
P